Booster
Overview
Booster is a New Zealand-owned financial services company that manages KiwiSaver, superannuation, and investment funds, and invests in New Zealand companies through specialist funds focused on early-stage innovation, private equity, and property.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wellumio | Jul 2026 | Early Funding | Co-investor |
| Amaroq Therapeutics | Jul 2021 | Seed | Co-investor |
| MACSO Technologies | Jul 2023 | Pre Seed | Co-investor |
| Wych | Sep 2025 | Seed | Co-investor |
| Scentian Bio | Apr 2026 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Booster based?
Booster is headquartered in Wellington, New Zealand.
When was Booster founded?
Booster was founded in 1998.
How many portfolio companies does Booster have?
Booster has 5 portfolio companies in Caplight's dataset.
What are some companies in Booster's portfolio?
Portfolio companies visible on Caplight include Wellumio, Amaroq Therapeutics, MACSO Technologies, Wych, Scentian Bio.
What was Booster's most recent investment shown here?
Booster's most recent investment in this portfolio sample was in Wellumio in 2026.
What sectors does Booster focus on?
Booster focuses on Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech.
What company stages does Booster focus on?
Booster typically invests at the Early stage.
What is Booster's AUM?
Booster's assets under management are estimated between $5.4B and $5.4B.